Mitigating IL-12-induced toxicities: A path forward with TNF inhibition. Julia Davydova, Christopher J. LaRocca. Molecular Therapy Oncology, Volume 33, Issue 1 (Commentary). March 20, 2025.

Ad6-Based GM-CSF Expressing Vector Displays Oncolytic and Immunostimulatory Effects in an Immunocompetent Syrian Hamster Model of Cholangiocarcinoma. 

Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells. Sacha Robert, Natasha Ivelisse Roman, Christopher J. LaRocca, Julie Hanson Ostrander, Julia Davydova. Viruses, Volume 16, Issue 4. April 5, 2024

Interferon‐expressing oncolytic adenovirus+ chemoradiation inhibited pancreatic cancer growth in a hamster model. Shuhei Shinoda, Nikita S. Sharma, Naohiko Nakamura, Kazuho Inoko, Mizuho Sato-Dahlman, Paari Murugan, Julia Davydova, Masato Yamamoto. Cancer science, Volume 114, Issue 9. July 13, 2023

Development of Oncolytic Vectors Based on Human Adenovirus Type 6 for Cancer Treatment. Ivan D. Osipov, Valeriia A. Vasikhovskaia, Daria S. Zabelina, Sergei S. Kutseikin, Antonina A. Grazhdantseva, Galina V. Kochneva, Julia Davydova, Sergey V. Netesov and Margarita V. Romanenko. Viruses, Volume 15, Issue 1. January 7, 2023

Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer. Tatyana Gavrikova, Naohiko Nakamura, Julia Davydova, Emmanuel S. Antonarakis, Masato Yamamoto. Viruses, Volume 15, Issue 4. March 31, 2023

Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion. Matthew Glen Robertson, Benjamin Bruce Eidenschink, Eriko Iguchi, Stanislav O. Zakharkin, Christopher J. LaRocca, Ezequiel J. Tolosa, Mark J. Truty, Kari Jacobsen, Martin E. Fernandez-Zapico, and Julia Davydova. Molecular Therapy: Oncolytics, Volume 20. March, 2021

Adenovirus type 6: subtle structural distinctions from adenovirus type 5 result in essential differences in properties and perspectives for gene therapy. Margarita Romanenko, Ivan Osipov, Sergey V. Netesov, Julia Davydova. Pharmaceutics, Volume 13. September 8, 2021

Interferon Alpha-Expressing Oncolytic Adenovirus for Treatment of Esophageal Adenocarcinoma. Christopher J. LaRocca, Amanda O. Salzwedel, Mizuho Sato-Dahlman, Margarita Romanenko, Rafael Andrade, Julia Davydova, Masato Yamamoto. Annals of Surgical Oncology, Volume 28, Issue 13. July 29, 2021

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer. Mariya Shapovalova, Julia Davydova, Christine Henzler, Mark Daniel, Scott M. Dehm, Christopher A. Warlick, Aaron M. LeBeau. Oncotarget, Volume 9, Issue 94. November 30, 2018

Oncolytic Adenoviruses Targeted to Human Papilloma Virus-Positive Head and Neck Squamous Cell Carcinomas. Christopher J. LaRocca, Joohee Han, Amanda R. Oliveira, Julia Davydova, Mark Herzberg, Rajaram Gopalakrishnan, Masato Yamamoto. Oral Oncology, Volume 56. March 18, 2016.